DR. PRIYANKA KANEKAR
Dr.Roopa Naik, Dr. SIDDHARTH SANE
Abstract
MATERIALS AND METHODS: The randomised clinical trial done for a period of 1 year included 50 newly diagnosed OAG patients having IOP more than 20mmHg at 8 am. Patients were divided randomly into two equal groups such as Group A which was treated with Latanoprost 0.005% and Group B with Bimatoprost 0.01%. Patients were followed up on 30th and 60th day of treatment and IOP was recorded at 8am.
RESULTS: Difference between baseline and day 30 IOP of Right eye in group B was more than group A (p=0.001). Difference between baseline and day 30 IOP of Left eye in group B was also more than group A (p=0.003). Similarly significant difference was noted between baseline and day 60 IOP of both groups (p<0.05). CONCLUSION: Bimatoprost 0.01% is more efficacious than Latanoprost 0.005% in reducing intraocular pressure.[advanced_iframe src="https://view.officeapps.live.com/op/embed.aspx?src=https://aiosproceedings.s3.ap-southeast-1.amazonaws.com/2021/E-Poster/FP566.pptx" width="100%" height="608"]


Leave a Comment